Paras Healthcare IPO received a decent response from investors. By the end of the third day of subscription, the issue was oversubscription 2.23 times, according to NSE data. The issue commanded a grey market premium (GMP) of around 2%, suggesting expectations of modest listing gains above the issue price.
As of Day 2, the IPO had received subscriptions for 34% of the shares on offer, against a total issue size of 1.20 crore shares. The retail individual investor (RII) category was subscribed 1.31 times, against 21.96 lakh shares reserved for the segment.